Evidence map›Paper›PMID 31110954›Full record

ArticlePediatric gastroenterology, hepatology & nutrition2019

Propofol with and without Midazolam for Diagnostic Upper Gastrointestinal Endoscopies in Children.

Ulas Emre Akbulut, Seyfi Kartal, Ufuk Dogan, Gulgun Elif Akcali, Serap Kalayci, Hulya Kirci

Open access · hybridAbstract read
In one paragraph

Article in Pediatric gastroenterology, hepatology & nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Propofol alone versus midazolam plus propofol for sedation in outpatient endoscopic procedures: A randomized controlled trial.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ulas Emre AkbulutDepartment of Pediatric Gastroenterology Hepatology and Nutrition, University of Health Sciences, Antalya Education and Research Hospital, Antalya, Turkey.
Seyfi KartalDepartment of Anesthesiology and Intensive Care Medicine, University of Health Sciences, Kanuni Training and Research Hospital, Trabzon, Turkey.
Ufuk DoganDepartment of Anesthesiology and Intensive Care Medicine, University of Health Sciences, Kanuni Training and Research Hospital, Trabzon, Turkey.
Gulgun Elif AkcaliDepartment of Anesthesiology and Intensive Care Medicine, University of Health Sciences, Kanuni Training and Research Hospital, Trabzon, Turkey.
Serap KalayciDepartment of Anesthesiology and Intensive Care Medicine, University of Health Sciences, Kanuni Training and Research Hospital, Trabzon, Turkey.
Hulya KirciDepartment of Pediatric Gastroenterology Hepatology and Nutrition, University of Health Sciences, Kanuni Training and Research Hospital, Trabzon, Turkey.
Sağlık Bilimleri Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeVarious publications on the use of sedation and anesthesia for diagnostic procedures in children have demonstrated that no ideal agent is available. Although propofol has been widely used for sedation during esophagogastroduodenoscopy in children, adverse events including hypoxia and hypotension, are concerns in propofol-based sedation. Propofol is used in combination with other sedatives in order to reduce potential complications. We aimed to analyze whether the administration of midazolam would improve the safety and efficacy of propofol-based sedation in diagnostic esophagogastroduodenoscopies in children.

methodsWe retrospectively reviewed the hospital records of children who underwent diagnostic esophagogastroduodenoscopies during a 30-month period. Demographic characteristics, vital signs, medication dosages, induction times, sedation times, recovery times, and any complications observed, were examined.

resultsBaseline characteristics did not differ between the midazolam-propofol and propofol alone groups. No differences were observed between the two groups in terms of induction times, sedation times, recovery times, or the proportion of satisfactory endoscopist responses. No major procedural complications, such as cardiac arrest, apnea, or laryngospasm, occurred in any case. However, minor complications developed in 22 patients (10.7%), 17 (16.2%) in the midazolam-propofol group and five (5.0%) in the propofol alone group (

conclusionThe sedation protocol with propofol was safe and efficient. The administration of midazolam provided no additional benefit in propofol-based sedation.

Indexed as

ChildrenConscious sedationEndoscopyMidazolamPropofol

Identifiers

PMID31110954
PMCPMC6506432
OpenAlexW2944186055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.